Cargando…
The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment
Prostate cancer (PCa), the most commonly diagnosed cancer and second leading cause of male cancer death in Western societies, is typically androgen-dependent, a characteristic that underlies the rationale of androgen deprivation therapy (ADT). Approximately 90% of patients initially respond to ADT s...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210931/ https://www.ncbi.nlm.nih.gov/pubmed/25338271 http://dx.doi.org/10.3390/nu6104491 |
_version_ | 1782341475638444032 |
---|---|
author | Dueregger, Andrea Heidegger, Isabel Ofer, Philipp Perktold, Bernhard Ramoner, Reinhold Klocker, Helmut Eder, Iris E. |
author_facet | Dueregger, Andrea Heidegger, Isabel Ofer, Philipp Perktold, Bernhard Ramoner, Reinhold Klocker, Helmut Eder, Iris E. |
author_sort | Dueregger, Andrea |
collection | PubMed |
description | Prostate cancer (PCa), the most commonly diagnosed cancer and second leading cause of male cancer death in Western societies, is typically androgen-dependent, a characteristic that underlies the rationale of androgen deprivation therapy (ADT). Approximately 90% of patients initially respond to ADT strategies, however many experience side effects including hot flashes, cardiotoxicity, metabolic and musculoskeletal alterations. This review summarizes pre-clinical and clinical studies investigating the ability of dietary supplements to alleviate adverse effects arising from ADT. In particular, we focus on herbal compounds, phytoestrogens, selenium (Se), fatty acids (FA), calcium, and Vitamins D and E. Indeed, there is some evidence that calcium and Vitamin D can prevent the development of osteoporosis during ADT. On the other hand, caution should be taken with the antioxidants Se and Vitamin E until the basis underlying their respective association with type 2 diabetes mellitus and PCa tumor development has been clarified. However, many other promising supplements have not yet been subjected large-scale clinical trials making it difficult to assess their efficacy. Given the demographic trend of increased PCa diagnoses and dependence on ADT as a major therapeutic strategy, further studies are required to objectively evaluate these supplements as adjuvant for PCa patients receiving ADT. |
format | Online Article Text |
id | pubmed-4210931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-42109312014-10-28 The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment Dueregger, Andrea Heidegger, Isabel Ofer, Philipp Perktold, Bernhard Ramoner, Reinhold Klocker, Helmut Eder, Iris E. Nutrients Review Prostate cancer (PCa), the most commonly diagnosed cancer and second leading cause of male cancer death in Western societies, is typically androgen-dependent, a characteristic that underlies the rationale of androgen deprivation therapy (ADT). Approximately 90% of patients initially respond to ADT strategies, however many experience side effects including hot flashes, cardiotoxicity, metabolic and musculoskeletal alterations. This review summarizes pre-clinical and clinical studies investigating the ability of dietary supplements to alleviate adverse effects arising from ADT. In particular, we focus on herbal compounds, phytoestrogens, selenium (Se), fatty acids (FA), calcium, and Vitamins D and E. Indeed, there is some evidence that calcium and Vitamin D can prevent the development of osteoporosis during ADT. On the other hand, caution should be taken with the antioxidants Se and Vitamin E until the basis underlying their respective association with type 2 diabetes mellitus and PCa tumor development has been clarified. However, many other promising supplements have not yet been subjected large-scale clinical trials making it difficult to assess their efficacy. Given the demographic trend of increased PCa diagnoses and dependence on ADT as a major therapeutic strategy, further studies are required to objectively evaluate these supplements as adjuvant for PCa patients receiving ADT. MDPI 2014-10-21 /pmc/articles/PMC4210931/ /pubmed/25338271 http://dx.doi.org/10.3390/nu6104491 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dueregger, Andrea Heidegger, Isabel Ofer, Philipp Perktold, Bernhard Ramoner, Reinhold Klocker, Helmut Eder, Iris E. The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment |
title | The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment |
title_full | The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment |
title_fullStr | The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment |
title_full_unstemmed | The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment |
title_short | The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment |
title_sort | use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210931/ https://www.ncbi.nlm.nih.gov/pubmed/25338271 http://dx.doi.org/10.3390/nu6104491 |
work_keys_str_mv | AT duereggerandrea theuseofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT heideggerisabel theuseofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT oferphilipp theuseofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT perktoldbernhard theuseofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT ramonerreinhold theuseofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT klockerhelmut theuseofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT ederirise theuseofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT duereggerandrea useofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT heideggerisabel useofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT oferphilipp useofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT perktoldbernhard useofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT ramonerreinhold useofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT klockerhelmut useofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment AT ederirise useofdietarysupplementstoalleviateandrogendeprivationtherapysideeffectsduringprostatecancertreatment |